Genetic Ablation of Epidermal EGFR Reveals the Dynamic Origin of Adverse Effects of Anti-EGFR Therapy

Epidermal EGFR Controls Cutaneous Host Defense and Prevents Inflammation

(2013) B. M. Lichtenberger et al.   Science Translational Medicine

Epidermal growth factor receptor inhibits colitis-associated cancer in mice

(2012) Philip E. Dubé et al.   JOURNAL OF CLINICAL INVESTIGATION

Tetracyclines Convert the Osteoclastic-Differentiation Pathway of Progenitor Cells To Produce Dendritic Cell-like Cells

(2012) S. Kinugawa et al.   JOURNAL OF IMMUNOLOGY

Direct and indirect anticancer activity of bisphosphonates: A brief review of published literature

(2011) Michael Gnant et al.   CANCER TREATMENT REVIEWS

Colon-specific delivery of a probiotic-derived soluble protein ameliorates intestinal inflammation in mice through an EGFR-dependent mechanism

(2011) Fang Yan et al.   JOURNAL OF CLINICAL INVESTIGATION

A Critical Role for Macrophages in Promotion of Urethane-Induced Lung Carcinogenesis

(2011) R. Zaynagetdinov et al.   JOURNAL OF IMMUNOLOGY

The Black Box Illuminated: Signals and Signaling

(2011) Francesca Mascia et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Inflammatory Skin and Bowel Disease Linked toADAM17Deletion

(2011) Diana C. Blaydon et al.   NEW ENGLAND JOURNAL OF MEDICINE

Serum biomarkers as potential predictors of antitumor activity of cetuximab-containing therapy for locally advanced head and neck cancer

(2011) Athanassios Argiris et al.   ORAL ONCOLOGY

Clinical practice guidelines for the prevention and treatment of EGFR inhibitor-associated dermatologic toxicities

(2011) Mario E. Lacouture et al.   SUPPORTIVE CARE IN CANCER

Characterisation of the cutaneous pathology in non-small cell lung cancer (NSCLC) patients treated with the EGFR tyrosine kinase inhibitor erlotinib

(2010) Emma Guttman-Yassky et al.   EUROPEAN JOURNAL OF CANCER

Preliminary evidence for a role of mast cells in epidermal growth factor receptor inhibitor–induced pruritus

(2010) Peter Arne Gerber et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Investigation of papulopustular eruptions caused by cetuximab treatment shows altered differentiation markers and increases in inflammatory cytokines

(2009) S.S. Han et al.   BRITISH JOURNAL OF DERMATOLOGY

Association of progression-free survival, overall survival, and patient-reported outcomes by skin toxicity andKRASstatus in patients receiving panitumumab monotherapy

(2009) Marc Peeters et al.   CANCER

Tumor Necrosis Factor-  and Interleukin-1 Antagonists Alleviate Inflammatory Skin Changes Associated with Epidermal Growth Factor Receptor Antibody Therapy in Mice

(2009) D. Surguladze et al.   CANCER RESEARCH

Generation and validation of mice carrying a conditional allele of the epidermal growth factor receptor

(2009) Tang-Cheng Lee et al.   GENESIS

Molecular Response to Cetuximab and Efficacy of Preoperative Cetuximab-Based Chemoradiation in Rectal Cancer

(2009) Annelies Debucquoy et al.   JOURNAL OF CLINICAL ONCOLOGY

Isolation and short-term culture of primary keratinocytes, hair follicle populations and dermal cells from newborn mice and keratinocytes from adult mice for in vitro analysis and for grafting to immunodeficient mice

(2008) Ulrike Lichti et al.   Nature Protocols

EGFR Antagonists in Cancer Treatment

(2008) Fortunato Ciardiello et al.   NEW ENGLAND JOURNAL OF MEDICINE